LCRF Pilot Grant Program

Funding Agency:
Lung Cancer Research Foundation

The LCRF pilot grant program funds innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, early detection, disparities, and social determinants of health research, focused on one or more of the following topics:

  • Lung cancer biology
  • Prevention and screening for early detection
  • Identification of new biomarkers
  • Development of more effective and less toxic therapies including but not limited to targeted and immune-therapies
  • Genetic and gene-environment interactions
  • Interactions and contributions of multiple factors (e.g. smoking, genetics, environment, societal factors) to disparities in lung cancer outcomes
  • Mechanisms of sensitivity and resistance to lung cancer therapies
  • Bioengineering approaches to understanding and/or treating lung cancer (i.e., theranostics, biomaterials, nanotechnology, controlled-drug release, and gene-therapy)
  • Supportive measures for people with lung cancer and their families

These awards provide a maximum of $150,000 in funding over a period of two years to early- and mid-career investigators. For full details, eligibility criteria, and application instructions, please refer to the request for proposals.

Deadline for LOI: April 30, 2022

Agency Website

Areas of Interest

Eligibility Requirements

Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment.  Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status.



Amount Description

  • The maximum award amount is $150,000 for a period of two years (disbursed at $75,000 per year).

Funding Type



Grad/Prof Students
Junior Faculty
Medical Fellow/Resident
Post Doctoral Fellows


Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

April 30, 2022